BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22166808)

  • 1. Krüppel-like factors KLF2 and 6 and Ki-67 are direct targets of zoledronic acid in MCF-7 cells.
    Ebert R; Zeck S; Meissner-Weigl J; Klotz B; Rachner TD; Benad P; Klein-Hitpass L; Rudert M; Hofbauer LC; Jakob F
    Bone; 2012 Mar; 50(3):723-32. PubMed ID: 22166808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells.
    Ebert R; Meissner-Weigl J; Zeck S; Määttä J; Auriola S; Coimbra de Sousa S; Mentrup B; Graser S; Rachner TD; Hofbauer LC; Jakob F
    Mol Cancer; 2014 Dec; 13():265. PubMed ID: 25496233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro.
    Mitrofan LM; Pelkonen J; Mönkkönen J
    Bone; 2009 Dec; 45(6):1153-60. PubMed ID: 19699819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells.
    Räikkönen J; Mönkkönen H; Auriola S; Mönkkönen J
    Biochem Pharmacol; 2010 Mar; 79(5):777-83. PubMed ID: 19819230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines.
    Fragni M; Bonini SA; Bettinsoli P; Bodei S; Generali D; Bottini A; Spano PF; Memo M; Sigala S
    Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):529-38. PubMed ID: 26905520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
    Jagdev SP; Coleman RE; Shipman CM; Rostami-H A; Croucher PI
    Br J Cancer; 2001 Apr; 84(8):1126-34. PubMed ID: 11308265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation.
    Ebert R; Zeck S; Krug R; Meissner-Weigl J; Schneider D; Seefried L; Eulert J; Jakob F
    Bone; 2009 May; 44(5):858-64. PubMed ID: 19442618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
    Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
    J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
    Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
    Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.
    Gschwantler-Kaulich D; Weingartshofer S; Grunt TW; Mairhofer M; Tan Y; Gamper J; Singer CF
    PLoS One; 2017; 12(9):e0185566. PubMed ID: 28945801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines.
    Ibrahim T; Liverani C; Mercatali L; Sacanna E; Zanoni M; Fabbri F; Zoli W; Amadori D
    Int J Oncol; 2013 Apr; 42(4):1263-70. PubMed ID: 23403907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro.
    Mani J; Vallo S; Barth K; Makarević J; Juengel E; Bartsch G; Wiesner C; Haferkamp A; Blaheta RA
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):250-5. PubMed ID: 22450844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry.
    Jauhiainen M; Mönkkönen H; Räikkönen J; Mönkkönen J; Auriola S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):2967-75. PubMed ID: 19665949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.
    Surmeli Z; Gursoy P; Erdogan AP; Bozkurt E; Atmaca H; Uzunoglu S; Sezgin C; Şanlı UA; Uslu R; Karaca B
    Tumour Biol; 2016 Mar; 37(3):3665-73. PubMed ID: 26462835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.
    Räikkönen J; Crockett JC; Rogers MJ; Mönkkönen H; Auriola S; Mönkkönen J
    Br J Pharmacol; 2009 Jun; 157(3):427-35. PubMed ID: 19371349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
    Andreoli V; Gehrau RC; Bocco JL
    IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
    Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP
    Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid-induced IPP/ApppI production in vivo.
    Mönkkönen H; Ottewell PD; Kuokkanen J; Mönkkönen J; Auriola S; Holen I
    Life Sci; 2007 Sep; 81(13):1066-70. PubMed ID: 17850825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.